Grant: CIHR Fellowship
University of British Columbia
$135,000.00
Modulation of immune cell fate and function by the islet secretome in health and diabetes
EF 2023-24
Résumé
Type 1 diabetes (T1D) is an autoimmune disease that occurs when the immune system attacks and destroys the beta cells in the pancreas. Beta cells are responsible for producing the hormone insulin, which regulates the levels of sugar in the blood. There is currently no cure for T1D. The immune system is responsible for protection of our bodies against infections and cancers. Immune cells are very sensitive to changes in the levels of sugar and other nutrients in the body, which changes in T1D.
In this proposal, we will study how immune cells and cells in the pancreas communicate. This will enable us to understand why the immune system ends up killing our own insulin-producing cells, leading to T1D. We propose that changes in the nutritional environment surrounding beta cells may increase the response by immune cells, inducing an exaggerated immune attack and loss of beta cells. So, we will study nutrients and other factors that are secreted by beta cells and how these factors are received and metabolized by immune cells. We will study factors released by healthy beta cells, beta cells in diabetes, as well as beta cells that have been through stress such as high and low levels of sugar, or inflammatory stress. We will analyze how immune cells become activated after being exposed to these factors and try to turn off the pathways that are 'switched on' in immune cells in contact with stressed beta cells.
Our project aims to identify new ways to control and slow down the progression of T1D by focusing on the interaction between immune cells and insulin-producing beta cells in the pancreas. We hope to gain a better understanding of how changes in metabolism in immune cells may lead to the immune attack on beta cells in T1D, and design ways to alter these metabolic pathways in immune cells to prevent or slow T1D.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
492724
Name
de Brito Monteiro Lauar
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Modulation of immune cell fate and function by the islet secretome in health and diabetes
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Autoimmunity; Cell-Cell Communication; Diabetes; Immunometabolism; Intermediary Metabolism; Macrophages; Metabolomics; Mitochondria; Pancreatic Islets; T Cells
Abstract
Type 1 diabetes (T1D) is an autoimmune disease that occurs when the immune system attacks and destroys the beta cells in the pancreas. Beta cells are responsible for producing the hormone insulin, which regulates the levels of sugar in the blood. There is currently no cure for T1D. The immune system is responsible for protection of our bodies against infections and cancers. Immune cells are very sensitive to changes in the levels of sugar and other nutrients in the body, which changes in T1D.
In this proposal, we will study how immune cells and cells in the pancreas communicate. This will enable us to understand why the immune system ends up killing our own insulin-producing cells, leading to T1D. We propose that changes in the nutritional environment surrounding beta cells may increase the response by immune cells, inducing an exaggerated immune attack and loss of beta cells. So, we will study nutrients and other factors that are secreted by beta cells and how these factors are received and metabolized by immune cells. We will study factors released by healthy beta cells, beta cells in diabetes, as well as beta cells that have been through stress such as high and low levels of sugar, or inflammatory stress. We will analyze how immune cells become activated after being exposed to these factors and try to turn off the pathways that are 'switched on' in immune cells in contact with stressed beta cells.
Our project aims to identify new ways to control and slow down the progression of T1D by focusing on the interaction between immune cells and insulin-producing beta cells in the pancreas. We hope to gain a better understanding of how changes in metabolism in immune cells may lead to the immune attack on beta cells in T1D, and design ways to alter these metabolic pathways in immune cells to prevent or slow T1D.
Competitiondate
202310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
de Brito Monteiro, Lauar
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~